Cargando…

Rationale and Design of Assessing the Effectiveness of Short-Term Low-Dose Lithium Therapy in Averting Cardiac Surgery-Associated Acute Kidney Injury: A Randomized, Double Blinded, Placebo Controlled Pilot Trial

Background: Burgeoning pre-clinical evidence suggests that therapeutic targeting of glycogen synthase kinase 3β (GSK3β), a convergence point of multiple cellular protective signaling pathways, confers a beneficial effect on acute kidney injury (AKI) in experimental models. However, it remains unknow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharif, Sairah, Chen, Bohan, Brewster, Pamela, Chen, Tian, Dworkin, Lance, Gong, Rujun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236527/ https://www.ncbi.nlm.nih.gov/pubmed/34195206 http://dx.doi.org/10.3389/fmed.2021.639402

Ejemplares similares

Pharmacological Melanocortin 5 Receptor Activation Attenuates Glomerular Injury and Proteinuria in Rats With Puromycin Aminonucleoside Nephrosis
por: Chen, Bohan, et al.
Publicado: (2022)

Melanocortin System in Kidney Homeostasis and Disease: Novel Therapeutic Opportunities
por: Chang, Mingyang, et al.
Publicado: (2021)

Mineralocorticoid receptor: A hidden culprit for hemodialysis vascular access dysfunction
por: Chen, Bohan, et al.
Publicado: (2018)

Therapeutic Targeting of SGLT2: A New Era in the Treatment of Diabetes and Diabetic Kidney Disease
por: Shaffner, James, et al.
Publicado: (2021)

Microdose Lithium Protects against Pancreatic Islet Destruction and Renal Impairment in Streptozotocin-Elicited Diabetes
por: Zhang, Jiahui, et al.
Publicado: (2021)

Permissive effect of GSK3β on profibrogenic plasticity of renal tubular cells in progressive chronic kidney disease
por: Chen, Bohan, et al.
Publicado: (2021)

Age-related GSK3β overexpression drives podocyte senescence and glomerular aging
por: Fang, Yudong, et al.
Publicado: (2022)

Rationale and design of the prevention of paclitaxel-related neurological side effects with lithium trial – Protocol of a multicenter, randomized, double-blind, placebo- controlled proof-of-concept phase-2 clinical trial
por: Huehnchen, Petra, et al.
Publicado: (2022)

Rationale and design of Diabetes Prevention with active Vitamin D (DPVD): a randomised, double-blind, placebo-controlled study
por: Kawahara, Tetsuya, et al.
Publicado: (2016)

Averting Disease
Publicado: (1860)

Averting Disease
Publicado: (1876)

A randomized, 4-week double-blind placebo control study on the efficacy of donepezil augmentation of lithium for treatment of acute mania
por: Chen, Jing, et al.
Publicado: (2013)

The ageing kidney: Molecular mechanisms and clinical implications
por: Fang, Yudong, et al.
Publicado: (2020)

Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial
por: Dean, Olivia May, et al.
Publicado: (2014)

Inhibition of glycogen synthase kinase 3β prevents NSAID-induced acute kidney injury
por: Bao, Hao, et al.
Publicado: (2012)

Confidence limits for the averted infections ratio estimated via the counterfactual placebo incidence rate
por: Dunn, David T., et al.
Publicado: (2021)

The “Double A” phenotype: Portending Allgrove's syndrome and averting adrenal crisis
por: Goswami, Soumik, et al.
Publicado: (2012)

A Danger to Be Averted
Publicado: (1892)

Activation of mineralocorticoid receptor by ecdysone, an adaptogenic and anabolic ecdysteroid, promotes glomerular injury and proteinuria involving overactive GSK3β pathway signaling
por: Lu, Minglei, et al.
Publicado: (2018)

Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial
por: Akhondzadeh, Shahin, et al.
Publicado: (2003)

Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD)
por: Hansen, Baiba Hedegaard, et al.
Publicado: (2009)

Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
por: Tanaka, Atsushi, et al.
Publicado: (2017)

A 6 Week Randomized Double-Blind Placebo-Controlled Trial of Ziprasidone for the Acute Depressive Mixed State
por: Patkar, Ashwin, et al.
Publicado: (2012)

Kratom and Pain Tolerance: A Randomized, Placebo-Controlled, Double-Blind Study
por: Vicknasingam, Balasingam, et al.
Publicado: (2020)

Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
Publicado: (2013)

Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic Lateral Sclerosis (LiCALS) [Eudract number: 2008-006891-31]
por: Al-Chalabi, Ammar, et al.
Publicado: (2011)

Averting danger from within
por: Bashyam, Hema
Publicado: (2008)

A double-blind placebo needle for acupuncture research
por: Takakura, Nobuari, et al.
Publicado: (2007)

China Tongxinluo Study for myocardial protection in patients with Acute Myocardial Infarction (CTS-AMI): Rationale and design of a randomized, double-blind, placebo-controlled, multicenter clinical trial
por: Xu, Yi, et al.
Publicado: (2020)

Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]
por: Ostadal, Petr, et al.
Publicado: (2005)

Design and rationale for the randomised, double-blinded, placebo-controlled Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS) crossover study
por: Myat, Aung, et al.
Publicado: (2015)

Study protocol and rationale for a prospective, randomized, double-blind, placebo-controlled study to evaluate the effects of Ashwagandha (Withania somnifera) extract on nonrestorative sleep
por: Deshpande, Abhijit, et al.
Publicado: (2018)

Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive Garcinia mangostana Linn. (Mangosteen) Pericarp for Schizophrenia
por: Turner, Alyna, et al.
Publicado: (2019)

Lovastatin as an Adjuvant to Lithium for Treating Manic Phase of Bipolar Disorder: A 4-Week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Ghanizadeh, Ahmad, et al.
Publicado: (2014)

Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study
por: Bourin, Michel S, et al.
Publicado: (2014)

Randomized, Placebo-Controlled, Double-Blind Pilot Study of D-Cycloserine in Chronic Stroke
por: Butler, Andrew J., et al.
Publicado: (2015)

Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis
por: Dutta, Prosenjit, et al.
Publicado: (2019)

Traditional Chinese Herbal Patch for Short-Term Management of Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Wang, Xuezong, et al.
Publicado: (2012)

Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trial
por: Wali, Ramesh K., et al.
Publicado: (2018)

Efficacy of Dragon's blood cream on wound healing: A randomized, double-blind, placebo-controlled clinical trial
por: Namjoyan, Foroogh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m7qq02cf678s9bv8p8nn2lur51